Uric acid can enhance MAPK pathway-mediated proliferation in rat primary vascular smooth muscle cells via controlling of mitochondria and caspase-dependent cell death

References

• Maiuolo J, Oppedisano F, Gratteri S, et al. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14.
   PubMed Web of Science ®Google Scholar
• Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323–345.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Bakris GL, Borghi C, et al. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis. 2018;71(6):851–865.
   PubMed Web of Science ®Google Scholar
• Chaudhary K, Malhotra K, Sowers J, et al. Uric acid-key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3(3):208–220.
   PubMed Web of Science ®Google Scholar
• Moulin-Mares SR, Zaniqueli D, Oliosa PR, et al. Uric acid reference values: report on 1750 healthy Brazilian children and adolescents. Pediatr Res. 2020;2020:1–6.
   Google Scholar
• de Souza S, Reuter CP, Andersen LB, et al. Metabolic risk associated with liver enzymes, uric acid, and hemoglobin in adolescents. Pediatr Res. 2020;88(6):945–949.
   PubMed Web of Science ®Google Scholar
• Cardoso AS, Gonzaga NC, Medeiros CC, et al. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. Jornal de Pediatria. 2013;89(4):412–418.
   PubMed Web of Science ®Google Scholar
• El Din UAS, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review. J Adv Res. 2017;8(5):537–548.
   PubMed Web of Science ®Google Scholar
• Huang X-B, Zhang W-Q, Tang W-W, et al. Prevalence and associated factors of hyperuricemia among urban adults aged 35–79 years in southwestern China: a community-based cross-sectional study. Sci Rep. 2020;10(1):1–7.
   PubMed Web of Science ®Google Scholar
• Yang Q, Lu Y, Deng Y, et al. Homocysteine level is positively and independently associated with serum creatinine and urea nitrogen levels in old male patients with hypertension. Sci Rep. 2020;10(1):1–9.
   PubMed Web of Science ®Google Scholar
• Takase H, Kimura G, Dohi Y. Uric acid levels predict future blood pressure and new onset hypertension in the general Japanese population. J Hum Hypertens. 2014;28(9):529–534.
   PubMed Web of Science ®Google Scholar
• Shankar A, Klein R, Klein B, et al. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006;20(12):937–945.
   PubMed Web of Science ®Google Scholar
• South AM, Shaltout HA, Nixon PA, et al. Association of circulating uric acid and angiotensin-(1–7) in relation to higher blood pressure in adolescents and the influence of preterm birth. J Hum Hypertens. 2020;34(12):818–825.
   PubMed Web of Science ®Google Scholar
• Kurata A, Shigematsu Y, Higaki J. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res. 2005;28(2):133–139.
   PubMed Web of Science ®Google Scholar
• Lu Z, Dong B, Wu H, et al. Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens. 2009;23(2):113–121.
   PubMed Web of Science ®Google Scholar
• Cannon PJ, Stason WB, Demartini FE, et al. Hyperuricemia in primary and renal hypertension. New Eng J Med. 1966;275(9):457–464.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Feig DI, Herrera-Acosta J, et al. Resurrection of uric acid as a causal risk factor in essential hypertension. Am Heart Assoc. 2005;45(1):18–20.
   Google Scholar
• Johnson RJ, Kang D-H, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183–1190.
   PubMed Web of Science ®Google Scholar
• Tang L, Xu Y, Wei Y, et al. Uric acid induces the expression of TNF‑α via the ROS‑MAPK‑NF‑κB signaling pathway in rat vascular smooth muscle cells. Mol Med Rep. 2017;16(5):6928–6933.
   PubMed Web of Science ®Google Scholar
• Hu D, Yin C, Luo S, et al. Vascular smooth muscle cells contribute to atherosclerosis immunity. Front Immunol. 2019;10:1101.
   PubMed Web of Science ®Google Scholar
• Li H, Qian F, Liu H, et al. Elevated uric acid levels promote vascular smooth muscle cells (VSMC) proliferation via an NOD-like receptor protein 3 (NLRP3)-inflammasome-dependent mechanism. Med Sci Monit. 2019;25:8457.
   PubMed Web of Science ®Google Scholar
• Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–1293.
   PubMed Web of Science ®Google Scholar
• Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system. J Hypertens. 2008;26(2):269–275.
   PubMed Web of Science ®Google Scholar
• Kang D-H, Han L, Ouyang X, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol. 2005;25(5):425–433.
   PubMed Web of Science ®Google Scholar
• Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266(13):8604–8608.
   PubMed Web of Science ®Google Scholar
• Kırça M, Oğuz N, Çetin A, et al. Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ. J Recept Signal Transduct. 2017;37(2):167–173.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Kang D-H, Feng L, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002;40(3):355–360.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen H, Cao P, et al. Inflammatory cytokines induce caveolin‐1/β‐catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway. Cell Prolif. 2016;49(3):362–372.
   PubMed Web of Science ®Google Scholar
• Sugiura R, Satoh R, Ishiwata S, et al. Role of RNA-binding proteins in MAPK signal transduction pathway. J Signal Transduct. 2011;2011:109746.
   PubMedGoogle Scholar
• Yue J, López JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21(7):2346.
   PubMed Web of Science ®Google Scholar
• Verzola D, Ratto E, Villaggio B, et al. Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4. PLoS One. 2014;9(12):e115210.
   PubMed Web of Science ®Google Scholar
• Song C, Zhao X. Uric acid promotes oxidative stress and enhances vascular endothelial cell apoptosis in rats with middle cerebral artery occlusion. Biosci Rep. 2018;38(3):BSR20170939.
   PubMedGoogle Scholar
• Li Z, Sheng Y, Liu C, et al. Nox4 has a crucial role in uric acid‑induced oxidative stress and apoptosis in renal tubular cells. Mol Med Rep. 2016;13(5):4343–4348.
   PubMed Web of Science ®Google Scholar
• Yan B, Liu D, Zhu J, et al. The effects of hyperuricemia on the differentiation and proliferation of osteoblasts and vascular smooth muscle cells are implicated in the elevated risk of osteopenia and vascular calcification in gout: an in vivo and in vitro analysis. J Cell Biochem. 2019;120(12):19660–19672.
   PubMed Web of Science ®Google Scholar
• Romi MM, Arfian N, Tranggono U, et al. Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation. BMC Nephrol. 2017;18(1):1–8.
   PubMedGoogle Scholar
• Chen M, Lu X, Lu C, et al. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway. Arthritis Res Ther. 2018;20(1):1–12.
   PubMedGoogle Scholar
• Li P, Zhang L, Zhang M, et al. Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: a mechanism for uric acid-induced endothelial dysfunction. Int J Mol Med. 2016;37(4):989–997.
   PubMed Web of Science ®Google Scholar
• Gunther S, Alexander RW, Atkinson WJ, et al. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol. 1982;92(2):289–298.
   PubMed Web of Science ®Google Scholar
• Çetin A, Öztürk OH, Tokay A, et al. Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells. Pharmacology. 2007;79(1):27–33.
   PubMed Web of Science ®Google Scholar
• Oğuz N, Kırça M, Çetin A, et al. Effect of uric acid on inflammatory COX-2 and ROS pathways in vascular smooth muscle cells. J Recept Signal Transduct. 2017;37(5):500–505.
   PubMed Web of Science ®Google Scholar
• Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9(9):726–735.
   PubMed Web of Science ®Google Scholar
• Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23(16):2838–2849.
   PubMed Web of Science ®Google Scholar
• Llambi F, Moldoveanu T, Tait SW, et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Molecular Cell. 2011;44(4):517–531.
   PubMed Web of Science ®Google Scholar
• Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75(3):487–517.
   PubMed Web of Science ®Google Scholar
• Van Varik B, Rennenberg R, Reutelingsperger C, et al. Mechanisms of arterial remodeling: lessons from genetic diseases. Front Genet. 2012;3:290.
   PubMedGoogle Scholar
• Clément M, Chappell J, Raffort J, et al. Vascular smooth muscle cell plasticity and autophagy in dissecting aortic aneurysms. Arterioscler Thromb Vasc Biol. 2019;39(6):1149–1159.
   PubMed Web of Science ®Google Scholar
• Henderson EL, Geng Y-J, Sukhova GK, et al. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 1999;99(1):96–104.
   PubMed Web of Science ®Google Scholar
• Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13–40.
   PubMed Web of Science ®Google Scholar
• Basatemur GL, Jørgensen HF, Clarke MC, et al. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16(12):727–744.
   PubMed Web of Science ®Google Scholar
• Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and risk of stroke: a systematic review and meta‐analysis. Arthrit Care Res. 2009;61(7):885–892.
   Web of Science ®Google Scholar
• Mazzali M, Hughes J, Kim Y-G, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. hypertension. 2001;38(5):1101–1106.
   PubMed Web of Science ®Google Scholar
• Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol-Renal Physiol. 2002;282(6):F991–F997.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Mazzali M, Kang D-H, et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol. 2003;23(1):2–7.
   PubMed Web of Science ®Google Scholar
• Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Euro Heart J. 2006;27(10):1174–1181.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol-Renal Physiol. 2002;283(5):F1105–F1110.
   PubMed Web of Science ®Google Scholar
• Gaffo AL, Edwards NL, Saag KG. Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther. 2009;11(4):240–247.
   PubMed Web of Science ®Google Scholar
• Kang D-H, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13(12):2888–2897.
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda ÁR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537–549.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu W-Z, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduction. 2015;35(6):600–604.
   PubMed Web of Science ®Google Scholar
• Selim KA, Abdelrasoul H, Aboelmagd M, et al. The role of the MAPK signaling, topoisomerase and dietary bioactives in controlling cancer incidence. Diseases. 2017;5(2):13.
   Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37–40.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Jiang H, Chen J, et al. KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways. Int J Mol Med. 2018;41(3):1265–1274.
   PubMed Web of Science ®Google Scholar
• Lee G-L, Wu J-Y, Tsai C-S, et al. TLR4-activated MAPK-IL-6 axis regulates vascular smooth muscle cell function. Int J Mol Sci. 2016;17(9):1394.
   Web of Science ®Google Scholar
• Park HS, Quan KT, Han JH, et al. Rubiarbonone C inhibits platelet‐derived growth factor‐induced proliferation and migration of vascular smooth muscle cells through the focal adhesion kinase, MAPK and STAT3 Tyr705 signalling pathways. Br J Pharmacol. 2017;174(22):4140–4154.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang X, Gao L, et al. Cortistatin exerts antiproliferation and antimigration effects in vascular smooth muscle cells stimulated by Ang II through suppressing ERK1/2, p38 MAPK, JNK and ERK5 signaling pathways. Ann Transl Med. 2019;7(20):561–561.
   PubMed Web of Science ®Google Scholar
• Vendrov AE, Sumida A, Canugovi C, et al. NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis. Redox Biol. 2019;21:101063.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Wu Y, et al. Role of the balance of Akt and MAPK pathways in the exercise-regulated phenotype switching in spontaneously hypertensive rats. Int J Mol Sci. 2019;20(22):5690.
   Web of Science ®Google Scholar
• Bock FJ, Tait SW. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85–100.
   PubMed Web of Science ®Google Scholar
• Raudenská M, Balvan J, Masařík M. Cell death in head and neck cancer pathogenesis and treatment. Cell Death Dis. 2021;12(2):1–17.
   PubMed Web of Science ®Google Scholar
• Ping S, Li Y, Liu S, et al. Simultaneous increases in proliferation and apoptosis of vascular smooth muscle cells accelerate diabetic mouse venous atherosclerosis. PLoS One. 2015;10(10):e0141375.
   PubMed Web of Science ®Google Scholar
• Kale J, Osterlund EJ, Andrews DW. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ. 2018;25(1):65–80.
   PubMed Web of Science ®Google Scholar